Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2

NCT02943486 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Foot Ulcer, Diabetic

Interventions

OTHER: dac-MSCs
OTHER: MSCs
DRUG: Fitostimoline

Sponsor

Universidad Autónoma de Bucaramanga

Collaborators

[object Object]
[object Object]